GPS Wealth Strategies Group’s Axsome Therapeutics AXSM Stock Holding History

GPS Wealth Strategies Group’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18	Closed	-$2.19K	–	636
2025 Q3	$2.19K	Hold	18	–	–	﹤0.01%	1408
2025 Q2	$1.88K	Hold	18	–	–	﹤0.01%	1362
2025 Q1	$2.1K	Hold	18	–	–	﹤0.01%	1299
2024 Q4	$1.52K	Hold	18	–	–	﹤0.01%	1265
2024 Q3	$1.62K	Hold	18	–	–	﹤0.01%	1256
2024 Q2	$1.45K	Sell	18 -11	-38%	-$814	﹤0.01%	1237
2024 Q1	$2.31K	Hold	29	–	–	﹤0.01%	1116
2023 Q4	$2.31K	Hold	29	–	–	﹤0.01%	1104
2023 Q3	$2.03K	Buy	29 +18	+164%	+$1.35K	﹤0.01%	1113
2023 Q2	$790	Hold	11	–	–	﹤0.01%	1176
2023 Q1	$678	Buy	+11	New	+$723	﹤0.01%	1180
2022 Q4	–	Sell	-11	Closed	–	–	184
2022 Q3	$0	Hold	11	–	–	﹤0.01%	1127
2022 Q2	$0	Hold	11	–	–	﹤0.01%	1105
2022 Q1	$0	Buy	+11	New	+$341	﹤0.01%	1039

Other funds holding AXSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPS Wealth Strategies Group's AXSM Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Axsome Therapeutics (AXSM) in Q4 2025, closing a stake of 18 shares — an estimated $2.19K sold.

GPS Wealth Strategies Group first reported a position in AXSM in Q1 2022 and held it in 14 quarters. The position peaked at $2.31K in Q1 2024. 398 funds tracked by Wall St. Rank hold AXSM as of Q4 2025.

GPS Wealth Strategies Group reported no remaining Axsome Therapeutics position as of Q4 2025 after selling out during the quarter.
GPS Wealth Strategies Group sold 18 Axsome Therapeutics shares in Q4 2025, an estimated $2.19K.
GPS Wealth Strategies Group first reported a position in Axsome Therapeutics in Q1 2022 and held it in 14 quarters.
GPS Wealth Strategies Group's Axsome Therapeutics position peaked at $2.31K in Q1 2024.
398 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.